During this webinar, Thomas Hanke, EVP Head of Academic Partnerships at Evotec in Germany, will present his vision and experience on how the preclinical validation of translational academic research projects should be planned and executed, in relationship with its foreseen clinical applications.
Evotec is a biotechnology company that offers technological expertise to advance drug discovery and development in a co-creation model with pharmaceutical companies, biotechs, foundations, and government agencies; as well as CRO/CDMO services for the Biopharma R&D sector.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
ASTP brought the right structure and terminology to my knowledge of technology licensing.
René Widmer
ETH Transfer, Switzerland
Great networking and learning opportunities to share knowledge with colleagues from their various areas of expertise.
Bruno Woeran
Merinova OY - TII President, Finland
Great atmosphere to learn and to share experiences.
Maria Ruiz Novales
Interface-Enterprises - University of Liege, Belgium
Just perfect 3 days full of information and perfect communication.
Petr Kubečka
Palacký University Olomouc, Czech Republic
Organisation and speakers were great, so enthusiastic about their work and very good at transferring their knowledge.
Sarka Bartova
Research Centre Rez, Czech Republic
Join our newsletter and get the latest news